Publication | Closed Access

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

Tp53 MutationBreast OncologyMedicinePathologyCancer GenomicsBreast CancerTaxane-based Neoadjuvant ChemotherapyBrca-1 MethylationCancer GeneticsOncologyCell BiologyTumor Biology